导航

| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 15.10% | 59/72 |
| 近一周 | -2.17% | 41/76 |
| 近一月 | 0.28% | 28/75 |
| 近一季 | 1.16% | 41/74 |
| 近半年 | 15.74% | 44/74 |
| 近一年 | 11.12% | 60/72 |
| 近两年 | 53.79% | 29/68 |
| 近三年 | 107.61% | 5/40 |
| 成立以来 | 467.80% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
-10.76% 62/74 |
16.31% 23/74 |
10.94% 52/74 |
- - |
| 2024 | 32.68% 3/75 |
13.61% 3/67 |
7.20% 21/72 |
0.33% 58/74 |
8.58% 9/75 |
| 2023 | 38.84% 5/72 |
10.12% 7/57 |
18.21% 3/64 |
-3.79% 32/68 |
10.85% 18/72 |
| 2022 | -20.82% 24/46 |
-8.19% 16/43 |
-15.33% 36/45 |
1.86% 3/45 |
- 31/46 |
| 2021 | 22.45% 5/43 |
2.14% 132/312 |
7.83% 97/328 |
1.28% 37/358 |
9.77% 4/43 |
| 2020 | 26.93% 19/41 |
-12.32% 152/280 |
25.58% 76/295 |
8.56% 61/299 |
6.19% 190/305 |
| 2019 | 29.76% 6/35 |
10.91% 106/258 |
6.34% 12/268 |
2.93% 72/253 |
6.88% 120/266 |
| 2018 | 1.39% 2/31 |
- - |
- - |
- - |
-18.27% 203/241 |
| 2017 | 15.91% 27/30 |
- - |
- - |
- - |
- - |
| 2016 | 10.88% 4/31 |
- - |
- - |
- - |
- - |
| 2015 | 6.98% 4/30 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 易方达标普生物科技美元汇A | 0.2432 | 29.46% |
| 易方达标普生物科技美元汇C | 0.2399 | 28.01% |
| 汇安行业龙头混合A | 2.4323 | 22.37% |
| 华商致远回报混合A | 1.6762 | 21.58% |
| 广发生物科技指数美元(QDII)C | 0.2047 | 18.46% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)美元现汇 | 1.3424 | 17.84% |
| 华夏上证科创板半导体材料设备主题ETF联接C | 1.2373 | 17.83% |
| 宝盈国家安全沪港深股票C | 2.1469 | 17.42% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)人民币A | 1.3726 | 17.14% |
| 广发上海金ETF | 9.7032 | 16.81% |
| 嘉实美国成长股票人民币 VS. () |